Selera Medical Analysis: $500K Raised
What is Selera Medical?
Selera Medical develops a minimally invasive device-based treatment for heart failure, aimed at managing fluid overload and alleviating patient symptoms.
Employees
2
Founded
2023
Investors
- Y Combinator
- Fogarty Innovation
Product Features & Capabilities
- minimally invasive lymphatic offloading (MILO) procedure, leverages body's fluid management system, offloads trapped fluid, prevents fluid buildup, reduces symptoms like shortness of breath and fatigue, decreases hospitalizations, improves overall health and quality of life
How much Selera Medical raised
Pre-Seed - $500,000
April 3, 2024Lead Investor: Y Combinator
Who are the founders of Selera Medical
SA
Stacie Arechavala
Founder & CEO
KB
Kevin Bui
Co-founder & CTO
Market Focus
Selera Medical primarily focuses on the medical device industry, specifically developing treatments for heart failure through minimally invasive procedures.
Competitors Overview
Selera Medical operates in the heart failure treatment market, focusing on a device-based solution for fluid overload. Its main competitors include:
- Sequana Medical: This company is known for its alfapump® system, which is a fully implantable, programmable device designed to manage fluid ove
See something that needs updating? Suggest edits to this profile.